Key facts
| Price (PPV) | 427 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | tiotropium |
| Class | Drugs for obstructive airway diseases |
| ATC code | R03BB04 |
| Manufacturer | BOTTU S.A. |
| Presentation | 30 gelules + un inhalateur |
| Hospital price | 284 MAD |
| Data collected on | 9/8/2026 |
Indications
Le tiotropium est indiqué comme traitement bronchodilatateur continu destiné à soulager les symptômes des patients présentant une bronchopneumopathie chronique obstructive (BPCO).
Find an open pharmacy
On-call pharmacies near you
About Spiriva 18 µg
Spiriva 18 µg belongs to the drugs for obstructive airway diseases therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Spiriva 18 µg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Spiriva 18 µg
Answers to common questions from Moroccan patients about this drug.